June 12, 2024


A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London

Image: Hollie Adams (Reuters)

In December of 2017, the FDA approved Novo Nordisk’s semaglutide (brand name Ozempic) for the treatment of type-2 diabetes. The even more convenient weekly injection becomes known, like all other GLP-1 drugs, for its weight loss side effects.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *